Medexus Pharmaceuticals Reports Record Revenue of $27.5 Million and $5.0 Million of Adjusted EBITDA* for the First Quarter of Fiscal 2021
Stock Information for Medexus Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.